Complete Remission in a Patient with Human Herpes Virus-8 Negative Multicentric Castleman Disease Using CHOP Chemotherapy
Open Access
- 1 January 2009
- journal article
- Published by Korean Cancer Association in Cancer Research and Treatment
- Vol. 41 (2), 104-7
- https://doi.org/10.4143/crt.2009.41.2.104
Abstract
Multicentric Castleman disease (MCD) is a rare lymphoproliferative disorder. Although MCD pathogenesis is unclear, studies have suggested that human herpesvirus 8 (HHV-8) may be associated with the disorder. Recent reports have identified MCD cases without viral infection. A 43-year-old woman presented to our hospital for fever and myalgia of 6 months' duration. The complete blood count revealed an elevated leukocyte count (15.1x10(3)/microL) and a decreased hemoglobin level of 10.0 g/dL. The C-reactive protein level was elevated at 276.5 mg/L. Thoracic computed tomography (CT) scans revealed bilateral axillary lymphadenopathy. There was no evidence of HHV-8, human immunodeficiency virus (HIV), or Mycobacterium infection. Histologic evaluation of a lymph node biopsy from the left axilla yielded a diagnosis of MCD. Cyclophosphamide, adriamycin, vincristine, and prednisone (CHOP) were administered for a total of 4 cycles. The patient's fever and lymphadenopathy resolved after the course of chemotherapy. She has been in complete remission for 24 months at this writing. As previously reported, this case report suggests that MCD can develop without viral infection. CHOP chemotherapy may be an effective treatment option for newly diagnosed MCD patients.Keywords
This publication has 17 references indexed in Scilit:
- Long‐term remission in HIV‐negative patients with multicentric Castleman's disease using rituximabEuropean Journal of Haematology, 2005
- Failure of cidofovir in HIV-associated multicentric Castleman diseaseBlood, 2004
- Rituximab therapy for HIV-associated Castleman diseaseBlood, 2003
- A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibodyAnnals of Hematology, 2003
- Treatment of HIV-associated multicentric Castleman's disease with oral etoposideAmerican Journal of Hematology, 2001
- Increased Expression of Vascular Endothelial Growth Factor (VEGF) in Castleman's Disease: Proposed Pathomechanism of Vascular Proliferation in the Affected Lymph NodeLeukemia & Lymphoma, 2000
- Retinoic acid for treatment of multicentric Castleman's diseaseThe Lancet, 1999
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofollicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic reticulum cellsHistopathology, 1991
- A systemic lymphoproliferative disorder with morphologic features of Castlemanʼs diseaseThe American Journal of Surgical Pathology, 1983